| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Creatine Phosphate Impurity 30 |
磷酸肌酸雜質(zhì)1 |
98924-69-7 |
詳細
|
| Alendronic Acid Impurity 10 |
N-乙酰氨甲基膦酸 |
57637-97-5 |
詳細
|
| Sitagliptin Impurity 28 |
西他列汀雜質(zhì)28 |
898543-70-9 |
詳細
|
| Palbociclib Impurity 166 |
|
1206248-85-2 |
詳細
|
| Benzenesulfonic Acid Impurity 48 |
|
3939-71-7 |
詳細
|
| Pentoxyverine Monomer |
枸櫞酸噴托維林 |
77-23-6 |
詳細
|
| Vardenafil Monomer |
伐地那非 |
224785-90-4 |
詳細
|
| Donepezil Impurity 67 |
3,4-二甲氧基肉桂酸 |
6443-72-7 |
詳細
|
| Domperidone Impurity 19 |
嗎丁啉雜質(zhì)12 |
107618-26-8 |
詳細
|
| 3-(2-methyl-1H-imidazole-1-yl)-5-(trifluoromethyl)aniline |
2-氨基-4-甲基苯甲酸乙酯 |
64818-80-0 |
詳細
|
| 3-(2,4-dimethyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-Benzenamine |
|
859026-97-4 |
詳細
|
| Acetylsalicylic Acid Impurity 27 |
3-甲?；?4-羥基苯甲酸 |
584-87-2 |
詳細
|
| Dapoxetine Impurity 114 |
N,N-二甲基-1-萘胺 |
86-56-6 |
詳細
|
| Desloratadine-d5 |
地氯雷他定D5 |
1020719-34-9 |
詳細
|
| Dasatinib Impurity 99 |
4,6-二氯-2-甲基嘧啶 |
1780-26-3 |
詳細
|
| Icotinib Impurity 15 |
|
1887066-21-8 |
詳細
|
| Icotinib Impurity 17 |
|
2376901-55-0 |
詳細
|
| Bixalomer |
N,N,N',N'-四(3-氨基丙基)-1,4-丁二胺 2-(氯甲基)環(huán)氧乙烷聚合物 |
851373-13-2 |
詳細
|
| Sarolaner Impurity 54 |
|
1575809-02-7 |
詳細
|
| Sarolaner Impurity 53 |
|
1398609-12-5 |
詳細
|
| Icotinib Impurity 21 |
|
1708935-20-9 |
詳細
|
| Icotinib Impurity 18 |
|
1318600-04-2 |
詳細
|
| Sarolaner Impurity 28 |
|
1575831-00-3 |
詳細
|
| Sarolaner Impurity 3 |
|
2131160-99-9 |
詳細
|
| Sarolaner Impurity 4 |
|
1398609-88-5 |
詳細
|
| Sarolaner Impurity 6 |
|
1398608-99-5 |
詳細
|
| Icotinib Impurity 19 |
|
1318600-10-0 |
詳細
|
| Disperse Yellow Impurity 4 |
|
15141-18-1 |
詳細
|
| Icotinib Impurity 8 |
|
153437-34-4 |
詳細
|
| Anagrelide Hydrochloride Hydrate |
|
823178-43-4 |
詳細
|
| Catechin Impurity 14 |
2-(3,4-二羥基苯基)-2-((2-(3,4-二羥基苯基)-5,7-二氫色滿-3-基)氧基)苯并二氫吡喃-3,4,5,7-四醇 |
20347-71-1 |
詳細
|
| Dabigatran Impurity 138 |
氯甲酸正己酯 |
6092-54-2 |
詳細
|
| Crizotinib Impurity 13 |
4-(4-溴吡唑-1-基)哌啶-1-甲酸叔丁酯 |
877399-50-3 |
詳細
|
| Rosiglitazone Maleate |
馬來酸羅格列酮 |
155141-29-0 |
詳細
|
| Benproperine Monomer |
苯丙哌林 |
2156-27-6 |
詳細
|
| Crisaborole Impurity 101 |
2-溴-3-羥基苯甲醛 |
196081-71-7 |
詳細
|
| Caprylic Acid Impurity 78 |
|
243139-64-2 |
詳細
|
| Fumagillin Impurity 1 |
O-(氯乙酰氨甲?；?煙曲霉素醇 |
129298-91-5 |
詳細
|
| Bilastine Impurity 34 |
2-[4-(2-氯乙酰基)苯基]-2-甲基丙酸甲酯 |
1638785-19-9 |
詳細
|
| Ritlecitinib Impurity 6 |
|
1207947-49-6 |
詳細
|
| Dopamine Impurity 86 |
3,4-二甲氧基-β-硝基苯乙烯 |
4230-93-7 |
詳細
|
| Icotinib Impurity 4 |
|
1058651-82-3 |
詳細
|
| Icotinib Impurity 3 |
|
1643673-51-1 |
詳細
|
| Icotinib Impurity 14 |
|
1887066-23-0 |
詳細
|
| Icotinib Impurity 13 |
|
610798-18-0 |
詳細
|
| Icotinib Impurity 10 |
|
2376901-56-1 |
詳細
|
| Ammonium hexafluorosilicate |
氟硅酸銨 |
16919-19-0 |
詳細
|
| Ritlecitinib |
利特昔替尼 |
1792180-81-4 |
詳細
|
| 1,2-Ethanediylbis[nitrilobis-(methylene)]]tetrakis-phosphonic acid |
乙二胺四亞甲基膦酸 |
1429-50-1 |
詳細
|
| Esmolol Impurity 67 |
肉桂酸 |
621-82-9 |
詳細
|
| Dicarboxylic acids, C4-6 |
草酸標(biāo)準(zhǔn)溶液 |
68603-87-2 |
詳細
|
| Diclofenac Impurity 15-d4 |
4-羥基雙氯芬酸-D4 |
254762-27-1 |
詳細
|
| Tiaprofenic Acid Impurity 7 |
2,4,6-三甲基苯甲酸 |
480-63-7 |
詳細
|
| Diltiazem Impurity 6 Monomer |
去乙酰地爾硫卓 |
42399-40-6 |
詳細
|
| Amino tris(methylene phosphonic acid) |
氨基三亞甲基膦酸 |
6419-19-8 |
詳細
|
| Dapoxetine Impurity 1 |
達泊西汀雜質(zhì)1 |
119357-22-1 |
詳細
|
| Dapoxetine Impurity 110 |
達泊西汀雜質(zhì) |
1329834-62-9 |
詳細
|
| Yohimbine Monomer |
育亨賓 |
146-48-5 |
詳細
|
| Darunavir Impurity 20 |
地瑞那韋雜質(zhì) 19 |
1402142-62-4 |
詳細
|
| Darunavir Impurity 18 |
達魯那韋雜質(zhì)7(S,S-異構(gòu)體) |
192800-79-6 |
詳細
|
| Lemborexant Impurity 1 |
萊博雷生中間體 |
528587-70-4 |
詳細
|
| Dasatinib Impurity 91 |
2,3-二氯-6-甲基苯胺 |
62077-27-4 |
詳細
|
| Dasatinib Impurity 90 |
2,4-二氯-6-甲基苯胺 |
30273-00-8 |
詳細
|
| Darunavir Impurity 21 |
達魯那韋雜質(zhì)9 |
1932330-83-0 |
詳細
|
| Butenafine Impurity 86 |
光蠟1013 |
1321-64-8 |
詳細
|
| Sorafenib Impurity 117 |
6-氯-2-吡啶羧酸甲酯 |
6636-55-1 |
詳細
|
| Sofosbuvir Impurity 146 |
|
129664-47-7 |
詳細
|
| Azithromycin Impurity 68 |
|
217500-34-0 |
詳細
|
| 5,8-Dibromo-1,2,3,4-tetrahydroquinoline |
|
7640-33-7 |
詳細
|
| Butenafine Impurity 77 |
1,8-二氯萘 |
2050-74-0 |
詳細
|
| Isocitric Acid Trisodium Salt |
異檸檬酸三鈉鹽 |
1637-73-6 |
詳細
|
| Galantamine Impurity 12 |
二氫加蘭他敏鹽酸鹽 |
21041-10-1 |
詳細
|
| Ifosfamide Impurity 16 |
N-甲基-2-羥基乙胺 |
109-83-1 |
詳細
|
| Dopamine Impurity 82 |
2-甲氧基-5-(2-硝基乙烯基)苯酚 |
39816-35-8 |
詳細
|
| Docetaxel Impurity 65 |
(3R,4S)-3-(三乙基硅氧基)-4-苯基-2-氧-氮雜環(huán)丁-1-甲酸叔丁酯 |
149198-47-0 |
詳細
|
| Lansoprazole Impurity 94 |
地蘭索拉唑雜質(zhì)7 |
1781244-56-1 |
詳細
|
| Ritlecitinib Impurity 2 |
N-BOC-6-甲基-3-氨基吡啶 |
323578-37-6 |
詳細
|
| Bixalomer Impurity 1 |
比沙洛姆雜質(zhì)1 |
120239-62-5 |
詳細
|
| Levodropropizine Impurity 37 |
哌嗪-1,4-二乙酸 |
5430-78-4 |
詳細
|
| Icotinib Impurity 1 |
|
1058651-74-3 |
詳細
|
| Clozapine Impurity 11 |
氯氮平雜質(zhì) |
1977-07-7 |
詳細
|
| PentacyanoaMine Ferrate AMMoniuM DisodiuM Salt |
二鈉五氰氨絡(luò)物高鐵酸鹽銨 |
36682-41-4 |
詳細
|
| Ritlecitinib Impurity 4 |
|
2101218-65-7 |
詳細
|
| Relugolix Impurity 147 |
瑞盧戈利雜質(zhì)65 |
2591260-03-4 |
詳細
|
| Phloroglucinol Impurity 202 Hydrate |
|
27735-64-4 |
詳細
|
| Butenafine Impurity 79 |
|
50402-52-3 |
詳細
|
| Adrenaline Impurity 15 Hydrochloride |
RAC N-甲基腎上腺素鹽酸鹽 |
62-22-6 |
詳細
|
| Prusogliptin Impurity 17 |
N-BOC-反式-4-羥基-D-脯氨酰胺 |
1613482-41-9 |
詳細
|
| Arginine Impurity 23 |
|
383177-47-7 |
詳細
|
| Azilsartan Impurity 121 |
阿齊沙坦雜質(zhì)121 |
1613135-56-0 |
詳細
|
| Sarolaner Impurity 1 |
|
1398609-00-1 |
詳細
|
| Buprenorphine Impurity 26 |
|
209963-02-0 |
詳細
|
| Milnacipran Impurity 13 |
|
871100-19-5 |
詳細
|
| Icotinib Impurity 5 |
|
2249867-59-0 |
詳細
|
| Caprylic Acid Impurity 81 |
|
1314994-88-1 |
詳細
|
| Cyclobenzaprine Impurity 16 |
環(huán)苯扎林雜質(zhì)7 |
1614-63-7 |
詳細
|
| Morphine Hydrochloride Impurity 2 Hydrate(Morphine Hydrochloride EP Impurity B Hydrate) |
|
6472-73-7 |
詳細
|
| Butenafine Impurity 80 |
|
53555-63-8 |
詳細
|
| Tosufloxacin p-Toluenesulfonate |
甲苯磺酸妥舒沙星 |
115964-29-9 |
詳細
|
| Dapoxetine Impurity 116 |
達泊西汀雜質(zhì)45 |
691-93-0 |
詳細
|